Form 4: Strata Critical Medical Officer Sells Shares for Tax

Strata Critical Medical's Chief Accounting Officer, Amir Cohen, disposed of 3,707 shares of Class A common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc. (SRTA), reported a transaction on September 10, 2025.
• The transaction involved the disposition of 3,707 shares of Class A common stock, with a par value of $0.0001 per share.
• These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units.
• The price per share for the disposition was $4.
• Following this transaction, Amir Cohen directly beneficially owns 100,053 shares of Class A common stock.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine, non-discretionary transaction for tax purposes related to RSU vesting, which is a common compensation event and does not reflect a change in management's outlook or company fundamentals.

Positives

• The underlying event, the vesting of restricted stock units, is a positive for the Chief Accounting Officer, indicating compensation realization.

Negatives

• No inherently negative aspects; the disposition is a mandatory tax-related event, not a discretionary sale indicating a lack of confidence in the company.

Risks

• No specific risks are disclosed in this Form 4 filing.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This is a routine insider transaction filing, common across all industries when executives' restricted stock units vest and shares are withheld for tax purposes. It does not provide specific industry-related insights.

Comparison to Industry Standards

• This type of transaction (shares withheld for tax upon RSU vesting) is a standard practice for executive compensation in publicly traded companies across all industries.
• It aligns with typical corporate governance and compensation structures for equity awards.

Stakeholder Impact

• Shareholders: Minimal impact, as it is a routine, non-discretionary transaction for tax purposes. It does not signal a change in management's confidence or company fundamentals.
• Employees: No direct impact on general employees.

Key Dates

Keywords

Strata Critical Medical, SRTA, Amir Cohen, Chief Accounting Officer, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, RSU vesting